Not Authorized
You are currently not authorized to access this section.
Please contact your Administrator to change your authorization settings.
Please contact your Administrator to change your authorization settings.
Company Overview
Orano Med's ambition is to develop a new generation of targeted cancer therapies thanks to the unique properties of lead-212 ( 212 Pb), a very rare alpha-emitting radioisotope.
Although research in oncology has made enormous progress in recent years, the medical needs for a wide range of cancers remain unmet. Our approach, better known as targeted alpha therapy, has the potential to bring significant benefits to patients who have not responded to existing treatments.
Although research in oncology has made enormous progress in recent years, the medical needs for a wide range of cancers remain unmet. Our approach, better known as targeted alpha therapy, has the potential to bring significant benefits to patients who have not responded to existing treatments.
Company Summary
Name
Orano Med, LLC.
Number of Employees
11-50
Website
Phone
(704) 805-2222